Clear Street’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History
Bought
Maintained
Sold
Other funds holding OACCW
AA
DAM
BGIM
WAM
LA
SCM
Clear Street's OACCW Position: Q1 2026 in Review
Clear Street held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q1 2026 at 8,876 shares worth $6.66K. The position accounts for ﹤0.01% of the portfolio, ranked #984.
Clear Street first reported a position in OACCW in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.77K in Q2 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.
- Clear Street held 8,876 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $6.66K as of Q1 2026.
- Clear Street left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q1 2026.
- Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #984 holding.
- Clear Street first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 6 quarters since.
- Clear Street's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $7.77K in Q2 2025.
- 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.
Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.